Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
105.20
+0.01 (0.01%)
At close: Aug 13, 2025, 4:00 PM
105.11
-0.09 (-0.09%)
After-hours: Aug 13, 2025, 7:41 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $9.07 billion as of August 13, 2025. Its market cap has increased by 394.60% in one year.
Market Cap
9.07B
Enterprise Value
8.87B
1-Year Change
394.60%
Ranking
Category
Stock Price
$105.20
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $9.07B, an increase of 5,129.19%. That is a compound annual growth rate of 61.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 9.07B | 138.60% |
| Dec 31, 2024 | 3.80B | 139.13% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |